OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: AAOI 45.77%
Applied Optoelectronics (AAOI) Earnings Call
NASDAQ: PSKY 24.52%
Warner Bros Discovery Deal: Why Netflix May Have Still Won
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: ACXIF 72.9%
NASDAQ: KORE 72.9%
NASDAQ: AAOI 72.9%
NASDAQ: PSKY 72.9%
